Human trials began last week, and the University of Oxford team hopes a million doses could be administered from September

These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus.

Scientists urge caution over hints of success emerging from small human and animal studies.

A VACCINE update has prompted excitement after the leader of the Oxford University coronavirus trials confirmed that the entire British population could be vaccinated by the end of the year.

Over the coming weeks, 300 healthy people will each be given two doses of the jab.

/PRNewswire/ -- A news report by Qu Jian from Science and Technology Daily: The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine,...

With governments all over the world pouring money into it, the effort to get a vaccine has come to resemble a more urgent version of the space race

The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?

Russia intends to be the first in the world to approve a coronavirus vaccine, in less than two weeks, CNN has learned. And despite concerns about its safety, effectiveness and over whether the...

Rising chorus of concern over Sputnik V vaccine stems from opaque development and lack of mass testing

Matt Hancock today dramatically raised hopes of a Covid-19 vaccine in the new year. The Health Secretary said it was “looking up” that the vaccine being developed by experts at the University of

The large, Phase 3 study testing the vaccine has been put on hold due to a suspected serious adverse reaction in a participant in the U.K.

The Financial Times reports that the U.K. will host the world's first human COVID-19 challenge trials, in which healthy volunteers are deliberately infected with coronavirus, in order to evaluate the...

The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug...